Logo image
KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation
Journal article

KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation

Timothy M Olson, Alexey E Alekseev, Christophe Moreau, Xiaoke K Liu, Leonid V Zingman, Takashi Miki, Susumu Seino, Samuel J Asirvatham, Arshad Jahangir and Andre Terzic
Nature clinical practice cardiovascular medicine, Vol.4(2), pp.110-116
02/2007
DOI: 10.1038/ncpcardio0792
PMCID: PMC2013306
PMID: 17245405

View Online

Abstract

A 53-year-old female presented with a 10-year history of paroxysmal atrial fibrillation (AF), precipitated by activity and refractory to medical therapy. In the absence of traditional risk factors for disease, a genetic defect in electrical homeostasis underlying stress-induced AF was explored. Echocardiography, cardiac perfusion stress imaging, invasive electrophysiology with isoproterenol provocation, genomic DNA sequencing of K(ATP) channel genes, exclusion of mutation in 2,000 individuals free of AF, reconstitution of channel defect with molecular phenotyping, and verification of pathogenic link in targeted knockout. K(ATP) channelopathy caused by missense mutation (Thr1547Ile) of the ABCC9 gene conferring predisposition to adrenergic AF originating from the vein of Marshall. Disruption of arrhythmogenic gene-environment substrate at the vein of Marshall by radiofrequency ablation.
Risk Assessment Coronary Vessels - physiopathology Humans Middle Aged Tachycardia, Paroxysmal - diagnostic imaging Treatment Outcome Mutation, Missense Atrial Fibrillation - genetics Atrial Fibrillation - surgery Tachycardia, Paroxysmal - genetics Channelopathies - therapy Catheter Ablation - methods Channelopathies - genetics ATP-Binding Cassette Transporters - genetics Atrial Fibrillation - diagnostic imaging Tachycardia, Paroxysmal - surgery Echocardiography, Doppler Kv1.5 Potassium Channel - genetics Female Chronic Disease

Details

Logo image